Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. (Q47592938)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2008

Language	Label	Description	Also known as
English	Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.	scientific article published on 25 August 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Ronjon Chakraverty

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Charles Craddock

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Antonio Pagliuca

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

B E Shaw

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

G J Mufti

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

S Mackinnon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

J D Cavenagh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

R M Pearce

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

K E Towlson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

J F Apperley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

M A Kazmi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

T J Littlewood

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

D W Milligan

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

K J Thomson

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

D I Marks

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

N H Russell

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

0 references

publication date

25 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

783-789

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18724393%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

21 January 2018

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47592938&oldid=2208657984"